Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

295.19
+3.741.28%
Post-market: 295.190.00000.00%19:38 EDT
Volume:887.56K
Turnover:262.16M
Market Cap:14.09B
PE:-60.47
High:298.18
Open:291.78
Low:289.07
Close:291.45
52wk High:299.32
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.02
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.96
PE(LYR):-101.36

Loading ...

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

Revvity Falls 15.5%, Bio-Techne Drops 10.1%, IQVIA Drops 8.3%, Charles River Down 7%

THOMSON REUTERS
·
Apr 23

Shares of Biotech and Medical Equipment Cos Fall After Thermo Fisher Results, Outlook

THOMSON REUTERS
·
Apr 23

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Charles River reports results of restrospective analysis on VCGs in toxicology

TIPRANKS
·
Apr 21

Charles River analysis finds virtual control groups match NOAEL outcomes in toxicology studies

Reuters
·
Apr 21

Is Cheaper Energy and Shipping Altering The Investment Case For Charles River Laboratories (CRL)?

Simply Wall St.
·
Apr 20

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

TradingKey
·
Apr 17

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 17

Charles River Labs sets first-quarter earnings release, conference call

Reuters
·
Apr 16

Charles River Labs : Barclays Raises Target Price to $210 From $200

THOMSON REUTERS
·
Apr 15

Charles River Labs Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

Charles River Laboratories Positioned as 'Leading' CRO as Preclinical R&D Inflection Nears, RBC Says

MT Newswires Live
·
Apr 14

RBC Initiates Charles River Laboratories International at Outperform With $215 Price Target

MT Newswires Live
·
Apr 14

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 14

FDA Rejection Sparks Questions On Replimune Drug Approval Path

Benzinga_recent_news
·
Apr 14

Earnings Season Is Here. Microsoft and 7 More Companies That Usually Deliver. -- Barrons.com

Dow Jones
·
Apr 13

Replimune says FDA’s CRL for RP1 ‘disappointing’

TIPRANKS
·
Apr 11

Replimune says FDA ‘appears to have contradicted their positions’ in CRL

TIPRANKS
·
Apr 11

Replimune downgraded to Neutral at Piper Sandler after second CRL

TIPRANKS
·
Apr 11